SectorBiological Technology
Established Date05/04/2011
Listing Date30/04/2013
ExchangeNASDAQ Stock Exchange
Full-time Employees24
Fiscal Year Ends31/12
Security TypeCommon stock
Office address2000 Sierra Point Parkway, Suite 400, Brisbane, California 94005
Business
IntroductionTempest Therapeutics Inc was founded on April 5, 2011. The Company is a clinical-stage oncology company focused on developing and advancing novel oral therapies for the treatment of solid tumors using a deep scientific understanding of cancer biology and medicinal chemistry. The company is advancing clinical trials of two product candidates, TPST-1120 and TPST-1495, which are believed to be the first clinical-stage molecules designed to inhibit their respective targets; and two preclinical projects, one of which may be the first to target TREX-1, a key cellular enzyme that regulates the innate immune response of tumors.
